Corvex logo

Corvex

North America, Minnesota, United States, Eden Prairie

Description

Corvex is the human capital management platform for frontline workers.

Investor Profile

Corvex has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Corvex frequently co-invest with?

Mubadala
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
Franklin Templeton
North America, California, United States, San Mateo
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 1

What are some of recent deals done by Corvex?

EQRx

Cambridge, Massachusetts, United States

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityDec 17, 2021
Amount Raised: $1,200,000,000
SomaLogic

Boulder, Colorado, United States

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Post Ipo EquitySep 1, 2021
Amount Raised: $375,000,000